Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy: One center’s experience
- 31 August 2002
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (8) , 860-866
- https://doi.org/10.1016/s1053-2498(02)00413-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cardiac Transplant VasculopathyChest, 2000
- Calcium channel blockers and angiotensin-converting enzyme inhibitors in the prevention of graft vasculopathyThe Journal of Heart and Lung Transplantation, 2000
- Percutaneous Revascularization Modalities in Heart Transplant RecipientsCatheterization and Cardiovascular Interventions, 1999
- Coronary stenting in cardiac allograft vasculopathyJournal of the American College of Cardiology, 1998
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- Cardiac allograft vasculopathy: Current conceptsAmerican Heart Journal, 1995
- Task force 5: ComplicationsJournal of the American College of Cardiology, 1993
- Coronary angioplasty in cardiac transplant patients. Results of a multicenter study.Circulation, 1992
- Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.Circulation, 1987